Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane)
about
Preclinical validation of interleukin 6 as a therapeutic target in multiple myelomaRequirements for innate immune pathways in environmentally induced autoimmunity.Genetic reporter system for oncogenic Igh-Myc translocations in mice.Immunopathogenesis of environmentally induced lupus in mice.RORγt modulates macrophage recruitment during a hydrocarbon oil-induced inflammationAnaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia.Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responsesDifferential development of oil granulomas induced by pristane injection in galectin-3 deficient miceDown-regulation of osteopontin attenuates breast tumour progression in vivoEndogenous RNA tumor viruses are activated during chemical induction of murine plasmacytomas.In vitro culture of primary plasmacytomas requires stromal cell feeder layers.Increased NHC Cells in the Peritoneal Cavity of Plasmacytoma Susceptible BALB/c Mouse.Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline.Evidence for the linkage of the IGC H locus to a gene controlling the idiotypic specificity of anti-p-azophenylarsonate antibodies in strain A mice.Six BALB-c IgA myeloma proteins that bind beta-(1-6)-D-galactan. Partial amino acid sequences and idiotypes.Immunochemical specificity of the combining site of murine myeloma protein CAL20 TEPC1035 reactive with dextrans.Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.Inhibition of plasmacytoma development in BALB/c mice by indomethacin.Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain GeneDetection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reactionBALB/c myeloma retroviruses have mink cell focus-inducing activity.Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.Clonal Immunoglobulin against Lysolipids in the Origin of MyelomaTLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.Production of neutralizing monoclonal antibodies to Escherichia coli heat-stable enterotoxin.Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.Type I interferon modulates monocyte recruitment and maturation in chronic inflammation.A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice.Adjuvants and autoimmunity.An acute phase response factor/NF-kappa B site downstream of the junB gene that mediates responsiveness to interleukin-6 in a murine plasmacytoma.Adjuvants and lymphoma risk as part of the ASIA spectrum.KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice.IL-1α modulates neutrophil recruitment in chronic inflammation induced by hydrocarbon oilInduction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane.Scientific Opinion on Mineral Oil Hydrocarbons in FoodAntigen-mediated regulation in monoclonal gammopathies and myeloma.Kaposi sarcoma-associated herpesvirus latency locus renders B cells hyperresponsive to secondary infectionsThe genetic landscape of 5T models for multiple myeloma3' enhancers hs3b/hs4 are dispensable for deregulation in mouse plasmacytomas with T(12;15) translocationsInduction of the ‘ASIA’ syndrome in NZB/NZWF1 mice after injection of complete Freund’s adjuvant (CFA)
P2860
Q27027729-C8599152-7783-41A0-9DEC-DBBFE384B509Q34655526-5FFB9670-21AE-478A-A06C-EFEB03F3C88AQ35026963-6987AAA4-CCD6-4B93-8567-2BE80BBE7A9AQ35029474-8C39B272-49A3-4D36-AB13-17AE04037782Q35048482-2168473C-2A44-498B-83DB-23FAC42FF455Q35055356-417EDB8B-545B-4665-A652-E2341FDDC292Q35127314-7CF1E526-DA91-4588-A153-A686EFAE4675Q35842426-31FAADEE-8ABB-4346-BAC6-30B3413A612BQ35886642-109BC9B4-8893-4B41-ACCB-2A347A9C42B5Q35991994-A951809A-E70B-49AD-8C57-77F408161F33Q36149289-1A6895A2-7F71-4242-BA25-BA327FB308F1Q36173295-67E29C18-83BF-4850-A50C-143A08A9EE83Q36270455-544AE961-15A3-4516-900C-AA3CE63B5AE9Q36272296-050C22A6-0731-417E-96F3-61207B6F06E6Q36272602-CA0ADCF1-6260-44C8-BCA6-A4B191E7927FQ36344382-62A8C146-D1C7-4BD2-BD9E-CAF275F1B4E3Q36348836-248211B7-E0B6-4EF9-8E57-246EE356FE63Q36350008-F8081BB1-2383-4D30-86F5-9F493385C401Q36384728-84D8CCF0-B332-47FA-9D44-C2B894EFA553Q36465052-A19C196E-3123-4F68-85FB-470B9EECF8ECQ36507712-EB2B8911-2039-4A53-A0DD-67A0D7017ADEQ36595626-D7D12DED-E76D-47A0-B8D7-F2C7CB3A8B86Q36719221-C9E13CAA-B83F-4488-B7F6-9D7E5E562A6CQ37019634-A615EA36-9202-4AB1-A7B9-B43869391F14Q37040303-46EB10EE-674D-443B-929C-0D2F0C693C44Q37351980-024C1BED-1C80-428B-A215-7B7B043B69BAQ37413679-CD4345DD-BC1C-41A7-8933-E03C8928988BQ37431980-B71407C3-6F76-4BB5-AA78-6520B1E63712Q37625591-54C0AD57-82A9-419C-8391-1E58B010E121Q38287690-1199CEFC-0285-4CDB-833D-316112E4EB43Q38316047-96A3F906-E4E3-4E6D-A765-7BBA960431DBQ38686974-800904AC-FC92-42E3-8FE2-F00971E9B5C1Q39274974-C8557DAD-4B33-45DC-8439-98A3672D599CQ41417294-8E608FE8-D782-442D-AED3-7F4D9F24175BQ47151832-5CEB7ED4-93F2-4DE8-AEA3-18514E807A97Q52579670-A6C38C71-17B7-4F14-BA4C-584A82FA98FFQ56345322-F167F422-F6CE-446D-A20A-267BA42E3F6AQ57292400-CF6A370B-54A1-4831-A185-9E389D438FDCQ57818341-A07E05A8-4612-409C-B1AE-BA90B18FAAA3Q58004256-EEB3F098-5208-491D-96BC-85B9D53E972B
P2860
Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane)
description
1969 nî lūn-bûn
@nan
1969 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1969 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1969年の論文
@ja
1969年論文
@yue
1969年論文
@zh-hant
1969年論文
@zh-hk
1969年論文
@zh-mo
1969年論文
@zh-tw
1969年论文
@wuu
name
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@ast
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@en
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@nl
type
label
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@ast
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@en
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@nl
prefLabel
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@ast
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@en
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@nl
P356
P1433
P1476
Induction of plasma cell tumou ...... ramethylpentadecane (pristane)
@en
P2093
P N Anderson
P2888
P356
10.1038/222994A0
P407
P577
1969-06-07T00:00:00Z
P6179
1015607712